| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |